Skip to content

Screener

Eligibility screening

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastati…

Sponsored by Qurgen Inc.Study detailsClinicalTrials.gov

5 US sites in AZ, MI, NC, OK +1

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.